Position in ENLV
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$8,727
+$2,271 QoQ
Shares Held
9,384
+2.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENLV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. ENLV ranks #296 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ENLV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,727 | 9,384 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,456 | 9,184 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $9,551 | 9,184 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,286 | 9,184 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,908 | 9,184 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,745 | 9,184 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,429 | 9,184 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,041 | 9,184 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $37,873 | 9,993 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $26,981 | 9,993 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $14,033 | 8,882 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,333 | 8,882 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $38,933 | 10,696 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $46,255 | 11,746 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $76,729 | 18,054 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $55,925 | 12,373 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $87,282 | 15,614 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $76,275 | 12,204 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $130,099 | 13,168 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $173,469 | 19,491 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $199,520 | 17,991 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,686 | 200 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||